Arabidopsis thaliana protein interaction network
Laboratório de Biologia Integrativa e Sistêmica (LaBIS)
Laboratório de Biologia Integrativa e Sistêmica (LaBIS)
Welcome to AtPIN
AtPIN will be upgraded. Please send your suggestions here
AT3G58780 - ( SHP1 (SHATTERPROOF 1) DNA binding / protein binding / transcription factor )
27 Proteins interacs with AT3G58780Locus | Method | FSW | Cellular Compartment Classification (C3) | Description |
---|---|---|---|---|
AT1G71692 | Experimental | FSW = 0.5396
| Class D:cytosol (p = 0.67) | AGL12 (AGAMOUS-LIKE 12) TRANSCRIPTION FACTOR |
AT5G27070 | Experimental | FSW = 0.1515
| Class D:nucleus (p = 0.78) | AGL53 TRANSCRIPTION FACTOR |
AT5G13790 | Experimentaltwo hybrid | FSW = 0.5152
| Class D:nucleus (p = 0.78) | AGL15 (AGAMOUS-LIKE 15) DNA BINDING / TRANSCRIPTION FACTOR |
AT4G24540 | Experimentaltwo hybrid | FSW = 0.5814
| Class D:nucleus (p = 0.78) | AGL24 (AGAMOUS-LIKE 24) PROTEIN BINDING / PROTEIN HETERODIMERIZATION/ PROTEIN HOMODIMERIZATION/ SEQUENCE-SPECIFIC DNA BINDING / TRANSCRIPTION FACTOR |
AT1G69120 | Experimental | FSW = 0.4877
| Class D:nucleus (p = 0.78) | AP1 (APETALA1) DNA BINDING / PROTEIN BINDING / PROTEIN HETERODIMERIZATION/ TRANSCRIPTION ACTIVATOR/ TRANSCRIPTION FACTOR |
AT1G24260 | Experimentaltwo hybridtwo hybridtwo hybrid3 hybrid method3 hybrid method3 hybrid method | FSW = 0.5185
| Class D:nucleus (p = 0.78)cytosol (p = 0.67) | SEP3 (SEPALLATA3) DNA BINDING / PROTEIN BINDING / TRANSCRIPTION FACTOR |
AT5G15800 | Experimentaltwo hybrid | FSW = 0.6649
| Class D:nucleus (p = 0.78)cytosol (p = 0.67) | SEP1 (SEPALLATA1) DNA BINDING / TRANSCRIPTION FACTOR |
AT3G57230 | Experimentaltwo hybrid | FSW = 0.6872
| Class D:nucleus (p = 0.78) | AGL16 (AGAMOUS-LIKE 16) TRANSCRIPTION FACTOR |
AT4G09960 | Experimentalpull down | FSW = 0.6437
| Class D:nucleus (p = 0.78) | STK (SEEDSTICK) PROTEIN BINDING / TRANSCRIPTION FACTOR |
AT5G23260 | Experimental3 hybrid method3 hybrid method | FSW = 0.4667
| Class D:nucleus (p = 0.78) | TT16 (TRANSPARENT TESTA16) TRANSCRIPTION FACTOR |
AT5G38620 | Experimental | FSW = 0.3508
| Class D:nucleus (p = 0.78) | MADS-BOX PROTEIN (AGL73) |
AT4G18960 | Experimental | FSW = 0.5352
| Class D:nucleus (p = 0.78) | AG (AGAMOUS) DNA BINDING / TRANSCRIPTION FACTOR |
AT2G42830 | Experimental | FSW = 0.6107
| Class D:nucleus (p = 0.78) | SHP2 (SHATTERPROOF 2) PROTEIN BINDING / TRANSCRIPTION FACTOR |
AT1G48150 | Experimentaltwo hybrid | FSW = 0.3130
| Class D:nucleus (p = 0.78) | MADS-BOX PROTEIN (AGL74 ) |
AT4G37940 | Experimentaltwo hybrid | FSW = 0.5418
| Class D:cytosol (p = 0.67) | AGL21 TRANSCRIPTION FACTOR |
AT2G22540 | Experimental | FSW = 0.4242
| Class D:nucleus (p = 0.78)cytosol (p = 0.67) | SVP (SHORT VEGETATIVE PHASE) TRANSCRIPTION FACTOR/ TRANSLATION REPRESSOR NUCLEIC ACID BINDING |
AT3G61120 | Experimentaltwo hybrid | FSW = 0.4444
| Class D:nucleus (p = 0.78)cytosol (p = 0.67) | AGL13 (AGAMOUS-LIKE 13) DNA BINDING / TRANSCRIPTION FACTOR |
AT2G45650 | Experimental | FSW = 0.6915
| Class D:nucleus (p = 0.78)cytosol (p = 0.67) | AGL6 (AGAMOUS-LIKE 6) DNA BINDING / TRANSCRIPTION FACTOR |
AT4G11880 | Experimental | FSW = 0.6342
| Class D:nucleus (p = 0.78) | AGL14 (AGAMOUS-LIKE 14) DNA BINDING / TRANSCRIPTION FACTOR |
AT2G45660 | Experimentaltwo hybrid | FSW = 0.5994
| Class D:nucleus (p = 0.78) | AGL20 (AGAMOUS-LIKE 20) TRANSCRIPTION FACTOR |
AT5G60910 | Experimental | FSW = 0.4964
| Class D:nucleus (p = 0.78) | AGL8 (AGAMOUS-LIKE 8) TRANSCRIPTION FACTOR |
AT3G16740 | Experimental | FSW = 0.0762
| Unknown | F-BOX FAMILY PROTEIN |
AT5G52640 | Predictedsynthetic growth defect | FSW = 0.0016
| Unknown | ATHSP901 (HEAT SHOCK PROTEIN 901) ATP BINDING / UNFOLDED PROTEIN BINDING |
AT4G36590 | PredictedGene fusion methodCo-expression | FSW = 0.0252
| Unknown | MADS-BOX PROTEIN (AGL40) |
AT3G54610 | PredictedPhenotypic Enhancement | FSW = 0.0185
| Unknown | GCN5 DNA BINDING / H3 HISTONE ACETYLTRANSFERASE/ HISTONE ACETYLTRANSFERASE |
AT2G03710 | Predictedtwo hybridtwo hybridAffinity Capture-Western | FSW = 0.2825
| Unknown | SEP4 (SEPALLATA 4) DNA BINDING / TRANSCRIPTION FACTOR |
AT5G62165 | Predictedinteraction prediction | FSW = 0.5760
| Unknown | AGL42 (AGAMOUS LIKE 42) TRANSCRIPTION FACTOR |
Downloads
Quick help
Experimental: This means that the indicated PPI was experimentally demonstrated using Arabidopsis thaliana proteins as model of study. The experiment indicated links to the publication of which this interaction was annotated from
Predicted: The indicated PPI was proposed based on ortholgs studies. The experiment indicated links to the publication of the orthologous PPI was annotated from
FSW
FSW is the Functional Similarity Weight. It represents the proportion of interaction partners that two proteins have in commonLearn more - FSWeight top ranked cut offs
C3
Class A: The PPI is a direct evidence (experimental), the subcellular location was experimentally demonstrated and both, target and source, were indicated as expressed in same cellular compartment
Class B: The PPI is a direct evidence (experimental), the subcellular location was experimentally demonstrated but both, target and source, were indicated as expressed in different cellular compartment
Class C: Same as Class A but the PPI is predicted
Class D: Same as Class A but subcellular location was predicted. P(exp|pred) indicates the probability of this particular predicted location be experimentally demonstrated given all data available on AtPINDB
Unknown: There is no available data to calculate the C3 or the data does not fit onto any class previously described
PEP
PEP is the posterior probability of this particular PPI be experimentally demonstrated once it was predicted. For this release p = 0.0030. If they share same cell compartment p = 0.0029Learn more
How to cite
If you find AtPIN interesting and want to use it in your work please cite usAtPIN: Arabidopsis thaliana Protein Interaction Network
Marcelo M Brandao, Luiza L Dantas and Marcio C Silva-Filho
BMC Bioinformatics 2009, 10:454DOI:1471-2105/10/454
Marcelo M Brandao, Luiza L Dantas and Marcio C Silva-Filho
BMC Bioinformatics 2009, 10:454DOI:1471-2105/10/454